Erickson Michael G's Form 4 filing
IDEXX Laboratories Inc (IDXX) · filed Feb 19, 2026
- Accession no.
- 0000874716-26-000033
- Filed
- Feb 19, 2026
- Trade date
- Feb 17-19, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 13 non-derivative transactions and 7 derivative transactions. Open-market sales total $3.37M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Erickson Michael GCIK 0002005385 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | MOption exerciseAcquired | +1,191 | $141.60 | +$168,645.6 | 13,884.35 | Direct | |
| Feb 17, 2026 | Common Stock | MOption exerciseAcquired | +4,180 | $178.26 | +$745,126.8 | 18,064.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −456 | $623.76 | −$284,434.56 | 17,608.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −204 | $625.24 | −$127,548.96 | 17,404.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −1,288 | $626.26 | −$806,622.88 | 16,116.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −2,694 | $628.22 | −$1,692,424.68 | 13,422.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −689 | $629.09 | −$433,443.01 | 12,733.35 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −40 | $629.86 | −$25,194.4 | 12,693.35 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +719 | $141.60 | +$101,810.4 | 13,412.35 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +817 | $178.26 | +$145,638.42 | 14,229.35 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +483 | $206.94 | +$99,952.02 | 14,712.35 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +183 | $544.08 | +$99,566.64 | 14,895.35 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseAcquired | +197 | $505.53 | +$99,589.41 | 15,092.35 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | MOption exerciseDisposed | −1,191 | $0.00 | $0 | 0 | Direct | |
| Feb 17, 2026 | Common Stock | MOption exerciseDisposed | −4,180 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −719 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −817 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −483 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −183 | $0.00 | $0 | 0 | Direct | |
| Feb 19, 2026 | Common Stock | MOption exerciseDisposed | −197 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.